Skip to main content
. 2020 Jun 30;37(2):148–157. doi: 10.36141/svdld.v37i2.8718

Fig. 1.

Fig. 1.

Cox regression analysis for survival in the prospective cohort. A. Two-group analysis (pirfenidone vs. no-pirfenidone); B. Three group analysis (full-dose pirfenidone, and reduced-dose pirfenidone vs. no-pirfenidone). The covariates were age, and % predicted forced vital capacity.